Zydus Lifesci. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
4,838.00
2,582.00
5,232.00
2,284.00
1,495.00
2,382.00
Adjustment
546.00
933.00
-2,117.00
1,163.00
1,474.00
539.00
Changes In working Capital
-871.00
-235.00
-336.00
191.00
263.00
-971.00
Cash Flow after changes in Working Capital
4,513.00
3,280.00
2,779.00
3,638.00
3,233.00
1,949.00
Cash Flow from Operating Activities
3,227.00
2,688.00
2,104.00
3,293.00
2,931.00
1,281.00
Cash Flow from Investing Activities
-1,492.00
1,541.00
-1,017.00
-836.00
-1,004.00
-3,977.00
Cash Flow from Financing Activities
-1,810.00
-4,400.00
-868.00
-2,547.00
-1,528.00
1,884.00
Net Cash Inflow / Outflow
-74.00
-170.00
218.00
-90.00
398.00
-810.00
Opening Cash & Cash Equivalents
487.00
657.00
888.00
1,177.00
778.00
1,589.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
7.00
Closing Cash & Cash Equivalent
413.00
487.00
1,106.00
1,087.00
1,177.00
778.00
Compare Cash Flow Results of Zydus Lifesci.
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
4838.1
2399.36
2,439.00
101.64%
Adjustment
546.7
212.2
334.00
157.63%
Changes In working Capital
-871.1
20.42
-891.00
-4365.92%
Cash Flow after changes in Working Capital
4513.7
2631.98
1,882.00
71.49%
Cash Flow from Operating Activities
3227.9
2152.45
1,075.00
49.96%
Cash Flow from Investing Activities
-1492.3
-2080.52
588.00
28.27%
Cash Flow from Financing Activities
-1810.4
5.27
-1,815.00
-34452.94%
Net Cash Inflow / Outflow
-74.8
77.19
-151.00
-196.90%
Opening Cash & Cash Equivalents
487.8
304.82
183.00
60.03%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
413
382.01
31.00
8.11%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 20.05% vs 27.76% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
3,227.90
2,688.80
20.05%